Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyros
2026-05-14
KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine delivers selective, high-potency CaMKII inhibition, enabling rigorous dissection of calcium signaling, insulin regulation, and cell cycle control. This guide translates bench-validated workflows and expert troubleshooting into actionable lab protocols, leveraging APExBIO’s trusted formulation for reproducible results.
-
ACSF3 Variant Drives Human Height and Metabolic Rate Evoluti
2026-05-14
Zhang et al. identify a regulatory variant (rs34590044-A) that upregulates ACSF3, simultaneously increasing human height and basal metabolic rate (BMR). This study reveals how metabolic homeostasis links genetic adaptation, dietary shifts, and key human phenotypes, with direct implications for metabolic and evolutionary biology.
-
Isradipine (Dynacirc) in Neuroprotection & Vascular Research
2026-05-13
Isradipine (Dynacirc) from APExBIO stands out as a high-purity, research-grade L-type calcium channel blocker, enabling precise interrogation of calcium-mediated processes in neurodegeneration and vascular smooth muscle function. This guide delivers actionable protocols, troubleshooting insights, and comparative context for scientists deploying isradipine in cutting-edge excitotoxicity and hypertension research.
-
2,5-di-tert-butylbenzene-1,4-diol (BHQ) in Calcium Signaling
2026-05-13
2,5-di-tert-butylbenzene-1,4-diol (BHQ) unlocks precise control over calcium homeostasis via selective SERCA inhibition, enabling advanced studies in hematopoietic stem cell mobilization and calcium signaling. This article delivers protocol enhancements, troubleshooting insight, and applied strategies for maximizing the translational impact of BHQ in both basic and preclinical workflows.
-
ML133 HCl: Precision Tool for Decoding Kir2.1 Channel Functi
2026-05-12
Explore how ML133 HCl, a selective potassium channel inhibitor, revolutionizes pulmonary artery smooth muscle cell proliferation research. This article unveils advanced assay strategies and practical insights unavailable elsewhere.
-
DNA Hypomethylation Reactivates TCN1 Autoantigen in Psoriasi
2026-05-12
This study identifies transcobalamin 1 (TCN1) as a novel keratinocyte-derived autoantigen in psoriasis, reactivated by DNA hypomethylation and driving T helper 17 cell activation. The findings highlight a mechanistic link between epigenetic deregulation and autoimmune inflammation, offering new avenues for both biomarker discovery and therapeutic intervention.
-
BHQ (2,5-di-tert-butylbenzene-1,4-diol): Beyond SERCA Inhibi
2026-05-11
Explore how 2,5-di-tert-butylbenzene-1,4-diol (BHQ) enables precise modulation of calcium homeostasis and advances hematopoietic stem cell mobilization strategies. This article delivers new, evidence-based insights into BHQ’s mechanism and translational value, distinct from existing overviews.
-
2,5-di-tert-butylbenzene-1,4-diol (BHQ): Precision Tool for
2026-05-11
Explore how 2,5-di-tert-butylbenzene-1,4-diol (BHQ) enables advanced calcium signaling research and stem cell mobilization by selectively inhibiting SERCA. This article offers a deeper, practical analysis of assay design and translational opportunities.
-
MLN8237 (Alisertib): Applied Workflows for Tumor Cell Apopto
2026-05-10
MLN8237 (Alisertib) empowers researchers to decode and modulate mitotic progression, delivering exceptional selectivity in apoptosis induction and tumor growth inhibition models. This guide translates advanced mechanistic findings into actionable, troubleshooting-ready workflows for cancer biology experiments.
-
KN-62: Precision CaMKII Inhibition for Translational Discove
2026-05-09
This article frames KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine, as a strategic tool for translational researchers seeking mechanistic clarity and reproducibility in calcium/calmodulin-dependent signaling, with deep dives into experimental design, workflow optimization, and the evolving landscape of kinase-targeted intervention.
-
EGTA (Egtazic Acid): Precision Calcium Modulation in Neuroph
2026-05-08
Explore how EGTA (egtzic acid) serves as a powerful, selective tool for modulating calcium signaling in neurophysiological and apoptosis assays. This article delivers a unique, experimentally grounded perspective linking molecular mechanisms to advanced assay design.
-
Dual-Action Inhibition Drives p38α MAPK Dephosphorylation Dy
2026-05-08
This study uncovers how dual-action kinase inhibitors, including those targeting p38α MAPK, accelerate the phosphatase-mediated dephosphorylation of the kinase activation loop by stabilizing specific inactive conformations. These insights inform the rational design of inhibitors for improved specificity and efficacy in cytokine and inflammation research.
-
ML-7 Hydrochloride: Deep Mechanistic Insights for MLCK Pathw
2026-05-07
Discover how ML-7 hydrochloride, a potent myosin light chain kinase inhibitor, enables advanced analysis of MLCK-mediated signaling in cardiac and endothelial models. This article offers unique mechanistic depth and translational context not found in typical protocol guides.
-
CD44-Driven Metabolic Rewiring in IDH-Mutant Leukemia Cells
2026-05-07
This study reveals that CD44-mediated metabolic rewiring is vital for sustaining NADPH production and high 2-hydroxyglutarate levels in IDH-mutant acute myeloid leukemia (AML). By demonstrating that CD44 supports a feedforward loop enabling oncometabolite synthesis and resistance to IDH1 inhibitors, the research opens new avenues for combinatorial therapies targeting both mutant IDH1 and CD44.
-
Diphenyleneiodonium Chloride: Precision Probe for Redox and
2026-05-06
Diphenyleneiodonium chloride (DPI) empowers researchers to dissect redox enzyme function and cAMP signaling pathways with high specificity. APExBIO's DPI stands out for its dual action as a NOX inhibitor and GPR3 agonist, making it the tool of choice for advanced oxidative stress and signaling studies.